July 6, 2024Open Access

Accumulation of CD56+ CD16- Natural Killer Cells in Response to Preoperative Chemotherapy for Breast Cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The activation of the antitumor immune responses of T cells and natural killer (NK) cells is important to induce breast tumor shrinkage via preoperative chemotherapy. We evaluated how antitumor immune responses contribute to the effects of such therapy.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Kim et al. (Sat,) studied this question.

synapsesocial.com/papers/68e6129eb6db6435875a5ae8 https://doi.org/https://doi.org/10.14740/wjon1885

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Natural killer cells in cancer biology and therapy2020 · 876 citations
2Axillary Lymph Node Status, Adjusted for Pathologic Complete Response in Breast and Axilla after Neoadjuvant Chemotherapy, Predicts Differential Disease-Free Survival in Breast Cancer2013 · 54 citations
3Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)2007 · 101 citations
4CD56brightCD16+ NK Cells: A Functional Intermediate Stage of NK Cell Differentiation2011 · 149 citations
5Why natural killer cells in triple negative breast cancer?2020 · 55 citations

Me gusta

Guardar

Ver artículo completo